Introduction
Newcastle disease (ND) is an acute, contagious infection of pet, free living and domestic birds. The causative agent is Newcastle disease virus (NDV) belongs to the genus Rubulavirus and falls in the subfamily Paramyxovirinae of the family Paramyxoviridae 1 . The virus is distributed all over the world either as naturally circulating virus or as a vaccine virus. ND is widely variable in type and severity of the disease it produces. It is complicated because different isolates and strains of the virus may induce variations in the severity of the disease even in a given host, such as, the chickens 2 . A variety of NDV isolates and strains have been recorded around the world [2] [3] .
ND may appear as Pneumotropic (Respiratory), Neurotropic (Nervous), Viscerotropic (visceral organs) and Velogenic viscerotropic (digestive system and other visceral organs). Among the strains that are of comparatively less virulence (Lentogenic) are B 1 , F and LaSota which have been widely used as vaccine. The least pathogenic (Lentogenic) strains B 1 4 , LaSota 5 , and F 6 are employed in birds of all ages by intra-nasal or intra-ocular instillation, admixture with drinking water, or spraying.
The control of ND relies on the use of safe and effective vaccines. Live vaccines prepared with lentogenic strains of NDV are now more commonly used in broilers than vaccines prepared from chemically inactivated strains of NDV, mixed with adjuvant 2 . This is because live freeze-dried vaccines can be produced on a large scale at a relatively low cost. The vaccines are easy to administer on a large scale, and rapidly stimulate humoral, cell-mediated and mucosal surface immunity.
Infections with NDV (either naturally or NDV vaccines) may induce cell-mediated immunity, humoral immunity, local immunity and passive immunity 1 In order to address one such query, the present study was undertaken to determine the maternally derived antibody of broiler chicks; to determine the antibody titer in chicks following vaccination with Medivac ND LaSota® (LaSota strain), BCRDV® (F-strain), Izovac B1 Hitchner® (B1 strain) and Cevac Vitapest L® (LaSota strain), and to evaluate the comparative antibody production of the vaccines used. 
Materials and Mathods

Newcastle disease vaccines
Preparation of antigen
The antigens of strain F, Asplin, BCRDV used for Hemagglutination (HA) and HI test were collected from the repository of the Department of Microbiology and Hygiene, Bangladesh Agriculture University (BAU), Mymensingh. The virus was grown in 10-day-old embryonated chicken egg via allantoic sac (AS) route and allantoic fluid (AF) was collected used as antigen described by Cottral 9 .
Vaccination of chicks and collection of sera
A total of 75 day-old chicks with the history of vaccination of parent stock against Newcastle disease (ND) were obtained for the experiment. After collection of blood at day 3 from 10 randomly selected birds, the birds were divided into 5 groups such as A, B, C, D and E and each group was reared separately from day 3. Group A, B, C and D were vaccinated with Medivac ND-LaSota®, BCRDV®, Izovac B1 Hitchner® and Cevac vitapest-L® respectively at 5 days of age through intraocular route, and then boostered at 21 days age of birds, while group E was maintained as unvaccinated control. After collection of blood, serum samples were collected on day 3, 15, 17, 19 and 31 from all the groups.
Collection and preparation of chicken red blood cell (cRBC) suspension
Blood samples collected from chicken with anticoagulant were washed with PBS and centrifuged at 500 rpm for 5 mins. Discarding the supernatant, cRBC was collected and prepared a 2% and 0.5% cRBC in PBS for slide and micro HA test and HI test respectively 10 . The unused cRBC suspension was stored at 4ºC until used.
Slide hemagglutination test
Drops of 2% chicken red blood cells were placed onto a clean glass slide. One drop of the control and test samples were added and mixed by rotating the slide and results were observed and recorded by comparing with the control samples. The red blood cells were agglutinated in positive case 11 .
Micro-haemagglutination test
It was carried out by two-fold serial dilutions of the viral suspension in a micro well plate to determine the haemagglutination titre of the HA antigen used (4 HA/25ul). For this purpose a 96 well 'V' bottomed micro plate was taken. Then 50 µl of PBS was dispatched in each well of the row A. Antigen (50 µl) was added to the first well, after thorough mixing serial dilution was continued up to the 11 well of the row A and finally discarded 50µl solution from the well 11. Well 12 considered as a control. Fifty microliter of 0.5% cRBC suspension was added into each well of the row A. The plate was allowed to stand for 45 min for reaction among the antigen and RBC at room temperature. An uniform layer of the agglutinated cells covering the bottom of well of the plate was considered as positive HA and in HA negative case, a sharp buttoning of RBC at the bottom of well of plate. The end point of the HA activity was considered to be the highest dilution of the antigen in which positive pattern of agglutination of RBC was present. The HA tire was calculated as the reciprocal of the highest dilution of antigen in which positive pattern of HA was present 11 .
Hemagglutination Inhibition test
The test is defined as the determination of antibody titer that inhibits the agglutination of RBC by the Newcastle disease virus. HI test in this study was performed to determine the HI of the sera samples collected from the chickens. The HI titer of sera samples of control chickens were determined to measure the maternal antibody and its persistence. The test was conducted by using constant 4 HA unit antigen and decreasing serum method (β procedure) following Anon 11 . The antigen was diluted in PBS to yield 4 HA units per 0.25 µl of suspension. The sera were heated at 56ºC for 30 minutes in hot water bath before using for the test. For performing the HI test, two fold serial dilution (starting from 1:5) of the serum was prepared in a 'V' bottomed microtitre plate. Then 25 µl of antigen suspension containing 4 HA units was added into all well except well number 12 of A, B, C, D, E, F, G and H as marked on the plate and mixed thoroughly. Well number 12 were kept as control. The serum antigen mixture was then incubated for 45 to 60 mins at room temperature. Then 50 µl of 0.6% chicken RBC suspension was added into all well. Then the mixture was again kept at room temperature for 60 mins. A compact mass of sediment cells covering the bottom of the plate was considered as positive for HI. The serum end point was determined as the highest dilution of serum, which inhibited the agglutination of the RBC in the test.
Results
The study was conducted to determine the persistence of maternally derived antibody 
Discussion
Vaccination as an effective control measure relies on two aspects. Firstly, vaccination of the parent stock to ensure that the progeny chicks are hatched with a high level of MDA and secondly, vaccination of the chickens with a suitable vaccine at the correct age. The resultant high level of MDA found in the progeny chickens is important in protecting the chickens during 10 to 14 days of age from NDV infection 12 .
One of the objectives of the present investigation was to detect the persistence of MDA in experimental chicks. Thus, it was observed ( Table 1 ) that such antibody remains in chicks until 19 days of age following which it declined to minimal. Moreover, in control group E high level of HI antibody titers were found during first two weeks of life which is closely related to the findings of Ibrahim 13 and Westbury 14 . The authors reported that MDA reduces the immune response to V4 vaccination.
It has also been reported that MDA in chicks is retained for 12 days to15 days [15] [16] . But after booster vaccination, the antibody levels are increased. Maternally derived antibody or passive immunity is the protective device for the prevention of many diseases in newly hatched chicks. Thus if a breeding hen is vaccinated against ND, some amount of resultant antibody produced and retained in the ova (yolk sac) are transmitted to the chick after hatch. These antibodies in turn protect the chick against ND for the first few days of age. In this regard it was observed that the MDA could be considered as an effective means of protection of the chickens till two weeks of age 15 . High level of MDA in day old chicks has been reported by Balla 17 and at day 15 to 20, protection levels declined to minimum. Saeed et al. 18 reported that MDA declined to zero at day 25. The immune response is improved in elder chicks as levels of maternal antibody fall and immunological maturity develops 19 .
The study was also undertaken to compare the production of antibody by vaccines of four lentogenic strains of Newcastle disease vaccines such as Medivac ND-LaSota (LaSota strain), BCRDV (F strain), Izovac B 1 Hitchner (B 1 strain) and Cevac vitapest-L (LaSota strain).
The results of HI antibody titre revealed that such titers are slightly higher in birds of group D vaccinated with Cevac Vitapest-L than those of group B administered with BCRDV, group C administered with Izovac B 1 Hitchner and also group A having inoculated with Medivac ND-LaSota (Table 1) .
A comparative illustration of HI antibody titres of sera samples obtained from birds of group A, B, C and D together with that of persistence of MDA in group E is presented in Table 1 In this context, the utility of measurement of HI antibodies of sera to qualify the protection capacity of birds from an infection with NDV needs to be mentioned. Lancaster 20 observed that serological response of chickens to NDV either from natural infection or vaccination is manifested by the appearance of both HI and VN (virus neutralization) antibodies. It was also started that HI and VN antibodies through follow a similar course but VN antibody persist longer and in relatively higher titers 21 . Concerned with the role of HI with the challenge infection with NDV, it was observed 22 . 
